Market Forecast By Regions (North America, Latin America, Europe, Asia Pacific, Middle East and Africa), By Product (Oral Contraceptive Pills, Injectable Birth Control, Emergency Contraceptive Pills, Vaginal Rings, Transdermal Patches), By Hormone (Progestin-Only Contraceptive, Combined Hormonal Contraceptive), By Age Group (15-24 Years, 25-34 Years, 35-44 Years, Above 44 Years), By End-Users (Hospitals, Household, Clinics) And Competitive Landscape
Product Code: ETC150182 | Publication Date: Dec 2021 | Updated Date: Mar 2025 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 300 | No. of Figures: 90 | No. of Tables: 30 | |
Report Name | Global Hormonal Contraceptives Market |
Forecast Period | 2025-2031 |
Market Size | USD 30.5 billion by 2031 |
CAGR | 5.8% |
Growing Sector | Oral Contraceptive Pills and Progestin-Only Contraceptives |
The Global Hormonal Contraceptives Market report provides a detailed analysis of market segments, by regions, product, hormone, age group and end-users. It offers an unbiased examination of current market trends, high-growth areas, and drivers to assist stakeholders in aligning their strategies with evolving market dynamics.
In 2025, the world organic birth control market earned about USD 19.4 billion. This large value of the market is proof for the utilization and dependence on hormone birth control approaches on a global scale. The market is expected to grow and reach about USD 26.8 billion in 2031. This development pattern shows the growing demand for contraception products, especially for women's health worldwide and the persistent efforts to improve their health risks.
The global market share for hormonal contraceptives is made up of different product ranges like contraception pills, IUDs, injectables, vaginal rings, implants, and transdermal patches. These ways make use of progestin-only and combined hormonal combinations to halt the pregnancy process. The increase in the market size depends on the points such as better education of family planning, comprehension of government policies, and technological progress in contraception systems
According to 6Wresearch, the Global Hormonal Contraceptives Market is anticipated to grow at a CAGR of 5.8% during the forecast period 2025-2031. One of the key factors that affects the hormonal contraceptives market is the rise of the knowledge and the acceptance of the various family planning methods. The governments and non-government organizations all over the world are introducing plans to the public that help people get to know the benefits of using contraceptives, with the primary goal of reducing unintentional pregnancies and make the health of pregnant women better. For example, according to the UN World Fertility and Family Planning 2022 report, in 2021, 1.9 billion women of reproductive age received some form of contraception to avoid pregnancy, with 77% of them using modern contraceptive methods, including implants, patches, IUDs, and others. Conventional contraceptive implementation is the other major influencing factor in these numbers. The research and development by pharma companies aiming at new and effective drugs are worth mentioning as one of the growth factors among this list. Innovations are here to minimize the restrictions of the current methods, as they have side effects and are difficult for the user to adhere to and the overall satisfaction to its users. This trend is reflected in the Global Hormonal Contraceptives Market Growth.
However, the sector of hormonal contraceptives is no cake walk, the barriers consist of cultural and religious opposition to contraceptive use in certain geographies which in turn can lead to people avoiding and opting out of hormonal contraceptives. Misinformation and probable side effects are the main causes of the indecision and non-adaptation of the concerned women to the use of hormonal contraceptives. The current positive influence of the wellness industry's promotion of natural over medical methods has resulted in a decline in the use of the more traditional hormonal contraceptives, those popular especially among the youth. The increased inclusion of more contraceptive options over the years has made some women dissatisfied with the ones that are widely known and preferred. It is not a secret the fact that the pharmaceutical industry should spend more funds for new products and innovations. And the lack of significant progress in hormone-free contraceptives is the result of incompletions in the researching of new and improved methods of contraceptives.
The newest development that is catching attention in hormonal contraceptives is the preference for long-acting reversible contraceptives (LARCs) such as IUDs and implants. These methods have a prolonged duration of action against pregnancy and need little attention from the user, which has made them very popular for those who are looking for convenient and reliable contraceptive options. The expected growth in the LARCs preference will bring the lift to the market in the coming years.
Say NO to the 3rd way trend is the production and approval AO of OTC contraception that is to be more accessible and convenient for users. Thus, the FDA milestone of having the sale of Opill, a progestin-only birth control pill, approved in the US over the counter, among a host of other developments, can be an instructive case study for making contraception more readily available.
Investors can reap good returns by coming up with new and distinct products that can fulfill the untapped needs in the hormonal contraceptives market. By concentrating on non-hormonal contraceptive methods or those with fewer side effects, the product can become more popular and gain a wider audience, which would include people who were reluctant to use the traditional hormonal options.
Another promising investment dimension is to extend the distribution channels to developing countries. During these regions' ever-increasing exposure and approval of contraceptive techniques, the very first problem to address will be the availability and affordability of these hormonal contraceptives which will help in capturing a significant market share. To bolster market penetration and growth, critiquing with local authorities and organizations to promote family planning programs is a plus.
The market for hormonal contraceptives is considered to consist several key players among them AbbVie Inc., Afaxys, Inc., Teva Pharmaceuticals Industries Ltd., Bayer AG, Organon Group of Companies, Pfizer, Agile Therapeutics, Janssen Pharmaceuticals Inc., Lupin Pharmaceuticals Inc., and Pregna International Ltd. These companies are not just passively involved in research and development but they are actually the ones who are significantly contributing to the growth of the healthcare sector through strategic partnerships and innovative products that also match the continuously changing consumers’ habits and preferences lines. ”- the company announced.
Federal mandates are relevant in driving the hormonal contraceptives industry. The U.S. Food and Drug Administration (FDA), and the European Medicines Agency (EMA) are regulatory bodies who prescribe instructions about how, to ensure the safety, efficacy, and quality of the hormonal contraceptive products. For these kinds of drugs or devices, these authorities mandate manufacturers to go through flawless clinical trials and testing before allowing their sale. These requirements are mandatory for a company to be granted a part in the market and for the trust of consumers to be successfully maintained.
In some states, countries are instructing policies that are directed in the promotion of contraceptive accessibility and affordability. As an example, the government health programs and insurance schemes in different areas cover the provision and distribution expenses of the contraceptive receptors, making it reallocation and access to those seeking them. Additionally, public health drives and paid-for educational instruction by governments that work on informing more people about the birth control methods and being responsible in the care of reproductive health.
Nevertheless, as much as it helps the manufacturing industry and the health service, those companies and medical providers face obstacles. The process of the approval of a new contraceptive product can drag out being both time-consuming and expensive mostly hitherto hindering the introduction of original solutions. Moreover, the variance in the political and regulatory practices of the different states leads to the formation of barriers to the entry of the market, thus prompting the companies to conform to different requirements in those regions.
Hormonal contraceptives market is projected to transform significantly in the next period. A primary development area is introducing brand-new, non-harmful contraceptive methods that have low side effects and high efficacy. Some of the potential changes are like the introductions of disposable contraceptives or the innovations of genital adjusted contraceptives. Now scientists are looking for the mechanism of action that turns them into contraceptives that do not produce side "rascal" effects. The scheme will be that the participants only take medicine when needed, and not as a regular dosage (Kasper2001.pdf, p. 14). I have taken some time to think about a diet, which gives me a feeling of well-being and ejaculation, the whole thing is simply to do with skincare. Researchers are exploring alternative hormone delivery systems, such as biodegradable implants and innovative oral formulations, to enhance user experience and compliance. These non-intrusive contraception options are a significant advantage of the biodegradable implants. The contraceptive therapy that prevents fertilization by enhancing motility and preventing the fusion of the epididymis and testis has a pH such that it remains in the epididymis and causes motility to rise. The effect of passive heating or cooling on the mobility of these cells is possible because the tissues are close to the surface. Tasking thermal control is strictly linked to sperm motility but, there are still many controversies about the influence of this mechanism on this particular life form that are opened.
The report offers a comprehensive study of the following market segments and their leading categories:
According to Ashutosh, Senior Research Analyst, 6Wresearch, The Americas have already achieved significant breakthroughs in the respective field. Ace K.Parellels Research & Consulting will launch a "Hormonal Contraceptives Market" product that will be available to farmers and purchases of their merchandise. The company is expanding the development of new products, which will be possible by the launching of five new products inclusively, within the first year period. The applicator of a hormonal contraceptive (device partner) projects to obtain a minimum share of 20% in the market in the near future due to the increasing awareness regarding contraception, the high prevalence of sex-related health problems, and the rise in the global population of pet animals.
Interrupted hormonal birth control is spoken for by the use of mini-pills (progestin-only), progesterone-releasing intrauterine devices (IUDs), and diaphragms with feminine barrier contraceptives, manufacturers are now following the demand for contraceptives. Underweight women may be strongly advised to stop taking these birth control pills. Around 135 million pill packs or other sources with as many as 30 million active women are accounting for its sales. Severe weight gain, rare allergies, VO2, and asthma are some of the drug's health and illegal side-effects of using the inhaler.
According to the needs, applications for mini-pills are also facetious. The various complexities of significant companies will not fail to be recognized; these may be placed as complementarities. The outflow of money in the pockets of the individual is reduced if free services are given. Hoot Foods, Inc., for example, has blueberries, apricots, golden raspberries, and red raspberries in their new sweetened purees. The development of new hybrids of plants by the bureau to help the farmers who can now plant the hybrids Agave nigra "Black Seed" and Agave McDougalli will encourage the negotiation with the buyers of these plants to obtain a reasonable amount of profit.
Between 25 and 34 years old, the highest demand for contraceptive pill is by women, who are the most fertile demographic group. Besides promotion of career-minded lifestyle, late childbirth, and thriving reproductive health consciousness are the factors behind the popularity of contraceptive methods among that generation. The availability of diverse contraceptive options meeting their needs continues to be a force that propels the market.
Hospitals will be the main end-users of hormonal contraceptives and will be the main areas where the contraceptives are distributed. It is common for women to go to healthcare professionals in hospitals for advice on which is the best contraceptive method to take, thus, the segment is likely to dominate the market. Also, Publicly Financed healthcare programs in hospitals improve access to contraceptive options thus touching on the growth of the market.
The report offers a comprehensive analysis of the following market segments
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Hormonal Contraceptives Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Hormonal Contraceptives Market Revenues & Volume, 2021 & 2031F |
3.3 Global Hormonal Contraceptives Market - Industry Life Cycle |
3.4 Global Hormonal Contraceptives Market - Porter's Five Forces |
3.5 Global Hormonal Contraceptives Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Hormonal Contraceptives Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Global Hormonal Contraceptives Market Revenues & Volume Share, By Hormone, 2021 & 2031F |
3.8 Global Hormonal Contraceptives Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.9 Global Hormonal Contraceptives Market Revenues & Volume Share, By End-users, 2021 & 2031F |
4 Global Hormonal Contraceptives Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Hormonal Contraceptives Market Trends |
6 Global Hormonal Contraceptives Market, 2021-2031 |
6.1 Global Hormonal Contraceptives Market, Revenues & Volume, By Product, 2021-2031 |
6.2 Global Hormonal Contraceptives Market, Revenues & Volume, By Hormone, 2021-2031 |
6.3 Global Hormonal Contraceptives Market, Revenues & Volume, By Age Group, 2021-2031 |
6.4 Global Hormonal Contraceptives Market, Revenues & Volume, By End-users, 2021-2031 |
7 North America Hormonal Contraceptives Market, 2021-2031 |
7.1 North America Hormonal Contraceptives Market, Revenues & Volume, By Product, 2021-2031 |
7.2 North America Hormonal Contraceptives Market, Revenues & Volume, By Hormone, 2021-2031 |
7.3 North America Hormonal Contraceptives Market, Revenues & Volume, By Age Group, 2021-2031 |
7.4 North America Hormonal Contraceptives Market, Revenues & Volume, By End-users, 2021-2031 |
8 Latin America Hormonal Contraceptives Market, 2021-2031 |
8.1 Latin America Hormonal Contraceptives Market, Revenues & Volume, By Product, 2021-2031 |
8.2 Latin America Hormonal Contraceptives Market, Revenues & Volume, By Hormone, 2021-2031 |
8.3 Latin America Hormonal Contraceptives Market, Revenues & Volume, By Age Group, 2021-2031 |
8.4 Latin America Hormonal Contraceptives Market, Revenues & Volume, By End-users, 2021-2031 |
9 Europe Hormonal Contraceptives Market, 2021-2031 |
9.1 Europe Hormonal Contraceptives Market, Revenues & Volume, By Product, 2021-2031 |
9.2 Europe Hormonal Contraceptives Market, Revenues & Volume, By Hormone, 2021-2031 |
9.3 Europe Hormonal Contraceptives Market, Revenues & Volume, By Age Group, 2021-2031 |
9.4 Europe Hormonal Contraceptives Market, Revenues & Volume, By End-users, 2021-2031 |
10 Asia Pacific Hormonal Contraceptives Market, 2021-2031 |
10.1 Asia Pacific Hormonal Contraceptives Market, Revenues & Volume, By Product, 2021-2031 |
10.2 Asia Pacific Hormonal Contraceptives Market, Revenues & Volume, By Hormone, 2021-2031 |
10.3 Asia Pacific Hormonal Contraceptives Market, Revenues & Volume, By Age Group, 2021-2031 |
10.4 Asia Pacific Hormonal Contraceptives Market, Revenues & Volume, By End-users, 2021-2031 |
11 Middle East Hormonal Contraceptives Market, 2021-2031 |
11.1 Middle East Hormonal Contraceptives Market, Revenues & Volume, By Product, 2021-2031 |
11.2 Middle East Hormonal Contraceptives Market, Revenues & Volume, By Hormone, 2021-2031 |
11.3 Middle East Hormonal Contraceptives Market, Revenues & Volume, By Age Group, 2021-2031 |
11.4 Middle East Hormonal Contraceptives Market, Revenues & Volume, By End-users, 2021-2031 |
12 Africa Hormonal Contraceptives Market, 2021-2031 |
12.1 Africa Hormonal Contraceptives Market, Revenues & Volume, By Product, 2021-2031 |
12.2 Africa Hormonal Contraceptives Market, Revenues & Volume, By Hormone, 2021-2031 |
12.3 Africa Hormonal Contraceptives Market, Revenues & Volume, By Age Group, 2021-2031 |
12.4 Africa Hormonal Contraceptives Market, Revenues & Volume, By End-users, 2021-2031 |
13 Global Hormonal Contraceptives Market Key Performance Indicators |
14 Global Hormonal Contraceptives Market - Opportunity Assessment |
14.1 Global Hormonal Contraceptives Market Opportunity Assessment, By Regions, 2021 & 2031F |
14.2 Global Hormonal Contraceptives Market Opportunity Assessment, By Product, 2021 & 2031F |
14.3 Global Hormonal Contraceptives Market Opportunity Assessment, By Hormone, 2021 & 2031F |
14.4 Global Hormonal Contraceptives Market Opportunity Assessment, By Age Group, 2021 & 2031F |
14.5 Global Hormonal Contraceptives Market Opportunity Assessment, By End-users, 2021 & 2031F |
15 Global Hormonal Contraceptives Market - Competitive Landscape |
15.1 Global Hormonal Contraceptives Market Revenue Share, By Companies, 2021 |
15.2 Global Hormonal Contraceptives Market Competitive Benchmarking, By Operating and Technical Parameters |
16 Company Profiles |
17 Recommendations |
18 Disclaimer |